Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Most people successfully navigate this adjustment period when they follow evidence-based management approaches and maintain realistic expectations about the timeline
What Current Evidence and Clinical Trials Tell Us The key published evidence is a 2023 Phase 2 RCT (Jastreboff et al.) showing substantial weight loss and predominantly mild-to-moderate GI side effects
Personalized Treatment: If eligible, you will receive a program tailored to your needs
2026-02-27 1400008639 Baxter is a registered trademark of Baxter International Inc
There may still be restrictions on the number of packets sold at one time for example
US$ 24.87
US$ 25.83
US$ 20.20
US$ 23.51
